World's Best Scientists 2026 revealed!
Michael P. Manns

Michael P. Manns

Award Badge
Best Scientists
2025
Award Badge
Immunology
Germany
2025

D-Index & Metrics

Best Scientists

D-Index
184
Citations
139911
World Ranking
526
National Ranking
17

Immunology

D-Index
185
Citations
141112
World Ranking
26
National Ranking
1

Medicine

D-Index
187
Citations
145244
World Ranking
282
National Ranking
6

Michael P. Manns publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael P. Manns sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 2,635 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael P. Manns D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael P. Manns sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 185 D-Index — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in Germany Leader Award
  • 2025 - Research.com Medicine in Germany Leader Award
  • 2023 - Research.com Immunology in Germany Leader Award
  • 2023 - Research.com Medicine in Germany Leader Award
  • 2022 - Research.com Immunology in Germany Leader Award
  • 2002 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Internal Medicine and Dermatology

Overview

Michael P. Manns is affiliated with Hannover Medical School in Germany and has contributed extensively to the field of Medicine, with a strong focus on Hepatology. Their publication record includes 293 works primarily centered on liver diseases and associated medical disciplines.

Their research spans several subfields, including:

  • Hepatology
  • Epidemiology
  • Surgery
  • Infectious Diseases
  • Immunology

Main topics addressed in their work cover:

  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Liver Disease and Transplantation
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders

Michael P. Manns has published multiple papers in frequent venues such as:

  • Journal of Hepatology
  • Liver International
  • Hepatology
  • Hepatology Communications
  • Zeitschrift für Gastroenterologie

Frequent coauthors collaborating on their research include:

  • Heiner Wedemeyer
  • Markus Cornberg
  • Benjamin Maasoumy
  • Stefan Zeuzem
  • Richard Taubert

The following papers represent select recent contributions of Michael P. Manns:

  • Breakthroughs in hepatitis C research: from discovery to cure, 2022, Nature Reviews Gastroenterology & Hepatology
  • The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology, 2020, Journal of Hepatology
  • PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis, 2020, Journal of Hepatology
  • Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases, 2021, Hepatology
  • MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma, 2020, Journal of Hepatology

Michael P. Manns was awarded membership in the German National Academy of Sciences Leopoldina in 2002, recognized in the fields of Internal Medicine and Dermatology.

Best Publications

  • International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

    F. Alvarez;P. A. Berg;F. B. Bianchi;L. Bianchi

  • EASL Clinical Practice Guidelines: Management of chronic hepatitis B

    C.P.G.P.P. Marcellin;G. Dusheiko;F. Zoulim;R. Esteban

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Diagnosis and management of autoimmune hepatitis.

    Michael P. Manns;Albert J. Czaja;James D. Gorham;Edward L. Krawitt

  • Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

    Chris Estes;Quentin M. Anstee;Maria Teresa Arias-Loste;Heike Bantel

  • Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

    Devin Razavi-Shearer;Ivane Gamkrelidze;Mindie H Nguyen;Ding-Shinn Chen

  • Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

    Tae-Won Kang;Tetyana Yevsa;Norman Woller;Lisa Hoenicke

  • Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

    Thierry Poynard;John McHutchison;Michael Manns;Christian Trepo

  • Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B

    Patrick Marcellin;E Jenny Heathcote;Maria Buti;Ed Gane

  • Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C

    John G. McHutchison;Michael Manns;Keyur Patel;Thierry Poynard

  • Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis C

    Gary L. Davis;John B. Wong;John G. McHutchison;Michael P. Manns

  • A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

    Bastian Hoechst;Lars A. Ormandy;Matthias Ballmaier;Frank Lehner

  • Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.

    Akinobu Takaki;Manfred Wiese;Geert Maertens;Erik Depla

  • Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

    Lars A. Ormandy;Tina Hillemann;Heiner Wedemeyer;Michael P. Manns

  • Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.

    Cara L. Mack;David Adams;David N. Assis;Nanda Kerkar

  • EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure.

    Julia Wendon;Juan Cordoba;Anil Dhawan;Fin Stolze Larsen

  • Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C

    Thierry Poynard;Vlad Ratziu;John McHutchison;Michael Manns

  • Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor

    Bastian Hoechst;Torsten Voigtlaender;Lars Ormandy;Jaba Gamrekelashvili

  • Thrombocytopenia associated with chronic liver disease

    Nezam Afdhal;John McHutchison;Robert Brown;Ira Jacobson

  • Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection

    Marc Bourlière;Stuart C. Gordon;Steven L. Flamm;Curtis L. Cooper

Frequent Co-Authors

Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School
Markus Cornberg
Markus Cornberg Hannover Medical School
Christian P. Strassburg
Christian P. Strassburg University Hospital Bonn
Christian Trautwein
Christian Trautwein RWTH Aachen University
Hans L. Tillmann
Hans L. Tillmann East Carolina University
Arndt Vogel
Arndt Vogel Hannover Medical School
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Tim F. Greten
Tim F. Greten National Institutes of Health
Stephan C. Bischoff
Stephan C. Bischoff University of Hohenheim
Sandra Ciesek
Sandra Ciesek Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology can open doors to a variety of healthcare careers, many of which benefit from advanced nursing degrees. For those considering a nursing path, exploring nurse practitioner accelerated program options can be an efficient way to move quickly into advanced practice roles.

If you are already a Family Nurse Practitioner (FNP) looking to specialize, learning how to transition from FNP to acute care NP is a valuable step. This career shift allows professionals to work with critically ill patients, which often demands additional certification and training but offers rewarding opportunities in fast-paced healthcare environments.

Many individuals without prior nursing experience are turning to online accelerated nursing programs for non nurses to start their healthcare journey. These programs provide a direct pathway into nursing, paving the way for future specialization in areas like immunology and acute care.

Compensation is also a critical consideration. Understanding dnp salary variations by state can help prospective students and professionals make informed decisions about where to study and work. This insight ensures alignment between career goals and financial expectations.

Best Scientists Citing Michael P. Manns

Trending Scientists

Recently Published Articles